Treatment of medication-related osteonecrosis of the jaw with cell therapy

Treatment of medication-related osteonecrosis of the jaw with cell therapy

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) poses a significant challenge considering the absence of a “gold standard” treatment. Cell-based therapy and tissue engineering offer promising therapeutic alternatives. This study aimed to harness the regenerative properties of adipo...

Full description

Bibliographic Details
Main Authors: Cyril Lucien Bouland, Rokneddine Javadian, Sarah Gilis, Antoine Yanni, Maxime Le Clercq, Pierre Mestrallet, Stelianos Kampouridis, Dominique Bron, Martin Lalmand, Xavier Vanden Eynden, Edward Boutremans, Didier Dequanter, Isabelle Loeb, Pierre Philippart, Laurence Lagneaux, Nathalie Meuleman
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
medication-related osteonecrosis of the jaw (MRONJ)
MRONJ
stromal vascular fraction (SVF)
SVF
leukocyte-platelet-rich fibrin
L-PRF
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2024.1338376/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2024.1338376/full

Similar Items